Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-17

Clinical Trial Update: HFS (High-Fiber Supplement) in MS (Multiple Sclerosis) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating a High-Fiber Supplement in individuals with Multiple Sclerosis, with results posted on 2024-12-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-Fiber Supplement

Snippet

Sponsor: Suhayl Dhib-Jalbut, MD | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-12-17